8-K
PERKINELMER INC false 0000031791 0000031791 2020-04-28 2020-04-28 0000031791 pki:Commonstock1parvaluepershareMember 2020-04-28 2020-04-28 0000031791 pki:M1.875NotesDue2026Member 2020-04-28 2020-04-28 0000031791 pki:M0.600NotesDue2021Member 2020-04-28 2020-04-28

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 28, 2020

 

PerkinElmer, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Massachusetts

 

001-05075

 

04-2052042

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

940 Winter Street, Waltham, Massachusetts

 

02451

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (781) 663-6900

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol

 

Name of exchange

on which registered

Common stock, $1 par value per share

 

PKI

 

The New York Stock Exchange

1.875% Notes due 2026

 

PKI 21A

 

The New York Stock Exchange

0.600% Notes due 2021

 

PKI 21B

 

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

At the annual meeting of shareholders of the Company held on April 28, 2020, the shareholders voted on the following proposals:

  a proposal to elect the eight nominees for director named below for terms of one year each;

  a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the current fiscal year; and

  a proposal to approve, by non-binding advisory vote, the Company’s executive compensation.

The shareholders elected each of the nominees to serve as a director for a term of one year. The final number of votes cast for or against or abstaining and the number of broker non-votes for each nominee are listed below. The proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm, and the proposal to approve, by non-binding advisory vote, the Company’s executive compensation, were each also approved. The final number of votes cast for or against or abstaining from voting on those two proposals and the number of broker non-votes on the executive compensation proposal are listed below.


Proposal #1 – To elect the following nominees as our directors for terms of one year each:

Name

 

Votes in Favor

   

Votes Against

   

Abstentions

   

Broker Non-Votes

 

Peter Barrett

   

96,186,244

     

1,995,906

     

708,059

     

5,395,681

 

Samuel R. Chapin

   

98,517,188

     

270,499

     

102,522

     

5,395,681

 

Sylvie Grégoire, PharmD

   

98,137,077

     

658,162

     

94,970

     

5,395,681

 

Alexis P. Michas

   

97,828,154

     

966,144

     

95,911

     

5,395,681

 

Prahlad R. Singh, PhD

   

98,508,435

     

281,691

     

100,083

     

5,395,681

 

Michel Vounatsos

   

98,522,437

     

270,113

     

97,659

     

5,395,681

 

Frank Witney, PhD

   

98,027,944

     

768,820

     

93,445

     

5,395,681

 

Pascale Witz

   

97,477,448

     

1,312,094

     

100,667

     

5,395,681

 

Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company’s independent public accounting firm for the current fiscal year.

For

   

Against

   

Abstain

   

Broker Non-Votes

 
 

102,378,167

     

1,702,853

     

204,870

     

0

 

Proposal #3 – To approve, by non-binding advisory vote, the Company’s executive compensation.

For

   

Against

   

Abstain

   

Broker Non-Votes

 
 

78,436,743

     

19,017,887

     

1,435,579

     

5,395,681

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PERKINELMER, INC.

         

Date: May 1, 2020

 

 

By: /s/ John L. Healy

         

 

 

John L. Healy

         

 

 

Vice President and Assistant Secretary